The bilirubin meters market size has grown strongly in recent years. It will grow from $0.49 billion in 2023 to $0.53 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth during the historic period can be attributed to increasing awareness of health conditions, supportive government policies and programs, a growing preference for home healthcare, an aging population, and economic development in emerging markets.
The bilirubin meters market size is expected to see strong growth in the next few years. It will grow to $0.71 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to the increasing incidence of neonatal jaundice, rising healthcare expenditure, the expansion of diagnostic centers, favorable reimbursement policies, and growth in medical tourism. Major trends expected during this period include innovations in bilirubin meter technology, development of hospital infrastructure, growing demand for point-of-care diagnostic devices, investments in research and development, and collaborations between manufacturers and healthcare providers.
The growing prevalence of liver diseases is expected to drive the expansion of the bilirubin meter market. Liver diseases include various conditions that affect liver function, often causing inflammation, scarring, or damage from factors such as infections, toxins, genetic disorders, or chronic diseases. The rise in liver diseases is attributed to increasing risk factors such as obesity, excessive alcohol consumption, viral infections, and lifestyle-related issues, alongside advancements in diagnostic capabilities. Bilirubin meters are crucial for managing these conditions as they provide accurate, non-invasive measurements of bilirubin levels, aiding in the diagnosis, monitoring, and treatment of liver dysfunction and jaundice. For example, a report from the Office for Health Improvement and Disparities in April 2024 indicated that premature deaths from hepatitis C have stabilized over the past three years, with 233 in 2022, 241 in 2021, and 237 in 2020. In 2022, England reported 5,776 premature deaths from alcoholic liver disease, with a rate of 11.6 deaths per 100,000 people under 75. Consequently, the increasing prevalence of liver diseases is fueling the growth of the bilirubin meter market.
Leading companies in the bilirubin meter market are focusing on developing advanced technologies, such as non-invasive bilirubin meters, to offer a quick, painless, and convenient method for monitoring bilirubin levels. Non-invasive bilirubin meters measure bilirubin without needing a blood sample, often using light-based techniques such as transcutaneous spectrophotometry. For instance, in November 2022, Yishan Medical, a China-based medical device company, introduced the Intelligent Neonatal Transdermal Jaundice Instrument. This device features exclusive optical detection technology developed by Yishan Medical, overcoming the cost barriers set by foreign technologies. Compact and user-friendly, it enhances portability and accessibility, making it ideal for primary jaundice monitoring in medical institutions and improving neonatal jaundice care at the primary healthcare level.
In December 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based medical device company, acquired DiaSys Diagnostic Systems GmbH for an undisclosed sum. This acquisition will help Mindray advance its supply chain platform, access an experienced international team, and strengthen its in-vitro diagnostics portfolio. Mindray plans to support DiaSys with resources and leverage its global integration experience to foster synergistic growth for both companies. DiaSys Diagnostic Systems GmbH is a Germany-based manufacturer of bilirubin meters.
Major companies operating in the bilirubin meters market are Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., PerkinElmer, Drägerwerk AG Co., Sysmex Corporation, Konica Minolta Business Solutions Inc., Masimo Corp., Beckman Coulter Inc., Nova Biomedical, Loewenstein Medical UK Ltd., Ningbo David Medical Device Co. Ltd., Reichert Inc., A. Menarini Diagnostics Srl, Mennen Co., Delta Medical International Ltd., AVI Healthcare Pvt Ltd., Olidef, Micro Lab Instruments, Aegis Medical Innovations Inc., Medi Waves Inc., Ginevri Srl.
North America was the largest region in the bilirubin meters market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bilirubin meters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bilirubin meters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
A bilirubin meter is a medical device used to measure bilirubin concentration in a patient's blood. These meters can be either invasive, requiring a blood sample, or non-invasive, using transcutaneous methods to measure bilirubin levels through the skin. Bilirubin meters are crucial for the accurate and timely diagnosis and management of conditions related to the liver and red blood cell breakdown.
The main types of bilirubin meters include transcutaneous devices and benchtop devices. Transcutaneous devices measure bilirubin levels through the skin without invasive procedures. These devices are used for both neonates and adults to monitor conditions such as jaundice and hepatitis. They are commonly employed in hospitals, medical centers, and other healthcare settings.
The bilirubin meters market research report is one of a series of new reports that provides bilirubin meters market statistics, including bilirubin meters industry global market size, regional shares, competitors with a bilirubin meters market share, detailed bilirubin meters market segments, market trends and opportunities, and any further data you may need to thrive in the bilirubin meters industry. This bilirubin meters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bilirubin meter market consists of sales of serum bilirubin analyzers, phototherapy equipment, disposable bilirubin test strips and neonatal blood collection kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The bilirubin meters market size is expected to see strong growth in the next few years. It will grow to $0.71 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to the increasing incidence of neonatal jaundice, rising healthcare expenditure, the expansion of diagnostic centers, favorable reimbursement policies, and growth in medical tourism. Major trends expected during this period include innovations in bilirubin meter technology, development of hospital infrastructure, growing demand for point-of-care diagnostic devices, investments in research and development, and collaborations between manufacturers and healthcare providers.
The growing prevalence of liver diseases is expected to drive the expansion of the bilirubin meter market. Liver diseases include various conditions that affect liver function, often causing inflammation, scarring, or damage from factors such as infections, toxins, genetic disorders, or chronic diseases. The rise in liver diseases is attributed to increasing risk factors such as obesity, excessive alcohol consumption, viral infections, and lifestyle-related issues, alongside advancements in diagnostic capabilities. Bilirubin meters are crucial for managing these conditions as they provide accurate, non-invasive measurements of bilirubin levels, aiding in the diagnosis, monitoring, and treatment of liver dysfunction and jaundice. For example, a report from the Office for Health Improvement and Disparities in April 2024 indicated that premature deaths from hepatitis C have stabilized over the past three years, with 233 in 2022, 241 in 2021, and 237 in 2020. In 2022, England reported 5,776 premature deaths from alcoholic liver disease, with a rate of 11.6 deaths per 100,000 people under 75. Consequently, the increasing prevalence of liver diseases is fueling the growth of the bilirubin meter market.
Leading companies in the bilirubin meter market are focusing on developing advanced technologies, such as non-invasive bilirubin meters, to offer a quick, painless, and convenient method for monitoring bilirubin levels. Non-invasive bilirubin meters measure bilirubin without needing a blood sample, often using light-based techniques such as transcutaneous spectrophotometry. For instance, in November 2022, Yishan Medical, a China-based medical device company, introduced the Intelligent Neonatal Transdermal Jaundice Instrument. This device features exclusive optical detection technology developed by Yishan Medical, overcoming the cost barriers set by foreign technologies. Compact and user-friendly, it enhances portability and accessibility, making it ideal for primary jaundice monitoring in medical institutions and improving neonatal jaundice care at the primary healthcare level.
In December 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based medical device company, acquired DiaSys Diagnostic Systems GmbH for an undisclosed sum. This acquisition will help Mindray advance its supply chain platform, access an experienced international team, and strengthen its in-vitro diagnostics portfolio. Mindray plans to support DiaSys with resources and leverage its global integration experience to foster synergistic growth for both companies. DiaSys Diagnostic Systems GmbH is a Germany-based manufacturer of bilirubin meters.
Major companies operating in the bilirubin meters market are Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., PerkinElmer, Drägerwerk AG Co., Sysmex Corporation, Konica Minolta Business Solutions Inc., Masimo Corp., Beckman Coulter Inc., Nova Biomedical, Loewenstein Medical UK Ltd., Ningbo David Medical Device Co. Ltd., Reichert Inc., A. Menarini Diagnostics Srl, Mennen Co., Delta Medical International Ltd., AVI Healthcare Pvt Ltd., Olidef, Micro Lab Instruments, Aegis Medical Innovations Inc., Medi Waves Inc., Ginevri Srl.
North America was the largest region in the bilirubin meters market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bilirubin meters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bilirubin meters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
A bilirubin meter is a medical device used to measure bilirubin concentration in a patient's blood. These meters can be either invasive, requiring a blood sample, or non-invasive, using transcutaneous methods to measure bilirubin levels through the skin. Bilirubin meters are crucial for the accurate and timely diagnosis and management of conditions related to the liver and red blood cell breakdown.
The main types of bilirubin meters include transcutaneous devices and benchtop devices. Transcutaneous devices measure bilirubin levels through the skin without invasive procedures. These devices are used for both neonates and adults to monitor conditions such as jaundice and hepatitis. They are commonly employed in hospitals, medical centers, and other healthcare settings.
The bilirubin meters market research report is one of a series of new reports that provides bilirubin meters market statistics, including bilirubin meters industry global market size, regional shares, competitors with a bilirubin meters market share, detailed bilirubin meters market segments, market trends and opportunities, and any further data you may need to thrive in the bilirubin meters industry. This bilirubin meters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bilirubin meter market consists of sales of serum bilirubin analyzers, phototherapy equipment, disposable bilirubin test strips and neonatal blood collection kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Bilirubin Meters Market Characteristics3. Bilirubin Meters Market Trends and Strategies32. Global Bilirubin Meters Market Competitive Benchmarking33. Global Bilirubin Meters Market Competitive Dashboard34. Key Mergers and Acquisitions in the Bilirubin Meters Market
4. Bilirubin Meters Market - Macro Economic Scenario
5. Global Bilirubin Meters Market Size and Growth
6. Bilirubin Meters Market Segmentation
7. Bilirubin Meters Market Regional and Country Analysis
8. Asia-Pacific Bilirubin Meters Market
9. China Bilirubin Meters Market
10. India Bilirubin Meters Market
11. Japan Bilirubin Meters Market
12. Australia Bilirubin Meters Market
13. Indonesia Bilirubin Meters Market
14. South Korea Bilirubin Meters Market
15. Western Europe Bilirubin Meters Market
16. UK Bilirubin Meters Market
17. Germany Bilirubin Meters Market
18. France Bilirubin Meters Market
19. Italy Bilirubin Meters Market
20. Spain Bilirubin Meters Market
21. Eastern Europe Bilirubin Meters Market
22. Russia Bilirubin Meters Market
23. North America Bilirubin Meters Market
24. USA Bilirubin Meters Market
25. Canada Bilirubin Meters Market
26. South America Bilirubin Meters Market
27. Brazil Bilirubin Meters Market
28. Middle East Bilirubin Meters Market
29. Africa Bilirubin Meters Market
30. Bilirubin Meters Market Competitive Landscape and Company Profiles
31. Bilirubin Meters Market Other Major and Innovative Companies
35. Bilirubin Meters Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Bilirubin Meters Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on bilirubin meters market which is experiencing strong growth. the report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for bilirubin meters? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bilirubin meters market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- the market characteristics section of the report defines and explains the market.
- the market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- the forecasts are made after considering the major factors currently impacting the market. These include:
- the impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- the impact of higher inflation in many countries and the resulting spike in interest rates.
- the continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- the regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- the competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- the trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Product: Transcutaneous Devices; Benchtop2) by Age Group: Neonates; Adults
3) by Indication: Jaundice; Hepatitis; Other Indications
4) by Application: Hospital; Medical Center; Other Applications
Key Companies Mentioned: Hoffmann-La Roche Ltd.; Abbott Laboratories; Siemens Healthineers AG; Koninklijke Philips N.V.; GE Healthcare
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- GE Healthcare
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- PerkinElmer
- Drägerwerk AG Co.
- Sysmex Corporation
- Konica Minolta Business Solutions Inc.
- Masimo Corp.
- Beckman Coulter Inc.
- Nova Biomedical
- Loewenstein Medical UK Ltd.
- Ningbo David Medical Device Co. Ltd.
- Reichert Inc.
- A. Menarini Diagnostics Srl
- Mennen Co.
- Delta Medical International Ltd.
- AVI Healthcare Pvt Ltd.
- Olidef
- Micro Lab Instruments
- Aegis Medical Innovations Inc.
- Medi Waves Inc.
- Ginevri Srl
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 175 |
Published | September 2024 |
Forecast Period | 2024 - 2028 |
Estimated Market Value ( USD | $ 0.53 Billion |
Forecasted Market Value ( USD | $ 0.71 Billion |
Compound Annual Growth Rate | 7.5% |
Regions Covered | Global |